Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from MSC2 cells treated with IL4

ABSTRACT: Expression data from MSC2 cells treated with IL4

PROVIDER: PRJNA434518 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

A549 cell Next Gen sequencing (RNA-seq) for differential gene expression of untreated versus IL4 or IL4+ALOX15 siRNA treated cells

Project description:Purpose: Identify genes regulated by ALOX15 in A549 cells that were treated with +/- IL4 and +/- ALOX15 siRNA by Next-gen sequencing

2024-04-03 | GSE171750 | GEO

Expression data from IL4 treatment in EML4-ALK-positive lung cancer cells.

Project description:Expression data from IL4 treatment in EML4-ALK-positive lung cancer cells.

| PRJNA730702 | ENA

Spleen vs IL4 Treated B cell

Project description:total RNA from mouse (male c57BL/6) spleen labeled with Cy3 vs total RNA from mouse (male c57BL/6) B cells treated with IL4 labeled with Cy5- time course with repeats Keywords: ordered

2003-04-14 | GSE386 | GEO

Normal human bronchial epithelial cell Next Gen sequencing (RNA-seq) for differential gene expression of untreated versus IL4 or IL4+ALOX15 siRNA treated cells

Project description:Purpose: Identify genes regulated by ALOX15 in Normal human bronchial epithelial (NHBE) cells that were treated with +/- IL4 and +/- ALOX15 siRNA by Next-gen sequencing

2024-04-03 | GSE179420 | GEO

Expression data from PEG-GNRs treated cells

Project description:Expression data from PEG-GNRs treated cells

| PRJNA408067 | ENA

Expression data from sulfisoxazole-treated cancer cells

Project description:Expression data from sulfisoxazole-treated cancer cells

| PRJNA483940 | ENA

A549 cell Next Gen sequencing (RNA-seq) for differential gene expression of untreated versus IL4 or IL4+ALOX15 siRNA treated cells

Project description:A549 cell Next Gen sequencing (RNA-seq) for differential gene expression of untreated versus IL4 or IL4+ALOX15 siRNA treated cells

| PRJNA720719 | ENA

Next Generation Sequencing Facilitates Quantitative Analysis of IL4/IL13 treated wild-type BMDMs

Project description:Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are to compare NGS-derived IL4/IL13 treated BMDMs transcriptome profiling (RNA-seq) to quantitative reverse transcription polymerase chain reaction (qRT–PCR) methods. Methods: BMDMs mRNA profiles of 8 weeks old wild-type (WT) mice were generated, stimulated with IL4/IL13, IL4/IL13+ TNF or TNF, deep sequenced, in triplicate, using Illumina NovaSeq 6000 platform. Results: Using an optimized data analysis workflow, we mapped about 30 million sequence reads per sample to the mouse genome (build mm9). Conclusions: Our study represents the first detailed analysis of IL4/IL13 or IL4/IL13+TNF stimulated BMDMs, with biologic replicates, generated by RNA-seq technology. The optimized data analysis workflows reported here should provide a framework for comparative investigations of expression profiles. Our results show that NGS offers a comprehensive and more accurate quantitative and qualitative evaluation of mRNA content within a cell or tissue. We conclude that RNA-seq based transcriptome characterization would expedite genetic network analyses and permit the dissection of complex biologic functions.

2021-05-04 | GSE169348 | GEO

Expression data of tigecycline-treated liver cancer cells

Project description:Expression data of tigecycline-treated liver cancer cells

| PRJNA821687 | ENA

Expression data from TGFβ1(TGFbeta1) treated HCC cells

Project description:Expression data from TGFβ1(TGFbeta1) treated HCC cells

| PRJNA809387 | ENA